This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Atorvastatin , a medication in the statin drug class , is prescribed to treat high cholesterol. Available in both tablet and liquid form, atorvastatin blocks the enzyme needed to make low-density lipoprotein (LDL) cholesterol (aka bad cholesterol) in the liver. Since high cholesterol can cause heart attacks and strokes, and this risk increases as people age, older adults may be more likely to need lipid-lowering agents like atorvastatin.
Imagine launching a breakthrough therapybut the right people never see it. In a world dominated by digital conversations, failing to master pharma digital marketing is no longer an optionits a risk to market performance. Pharma marketers today must navigate not only consumer expectations but also a tightly regulated environment. The stakes are high, but so are the opportunities.
People with Type 2 Diabetes have many treatment options these days, though not all are covered by insurance. Ozempic is a prescription weekly injection manufactured by Novo Nordisk. It is often covered by insurance when prescribed for diabetes (not weight loss ). However, not all insurance plans cover Ozempic and when it is covered, the coverage amount may vary by provider and plan.
A national public health organization is calling for Health Secretary Robert F. Kennedy Jr. to resign the federal post he assumed just weeks ago, citing “implicit and explicit bias and complete disregard for science.” Georges Benjamin, executive director of the American Public Health Association, said in a statement on Wednesday that concerns raised during Kennedy’s confirmation hearing last month have been realized, followed by massive reductions in staff at key health agen
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Depakote is a brand-name anticonvulsant medication that comes in an extended-release tablet , delayed-release tablet , and delayed-release capsule. Also referred to by its generic name divalproex sodium Depakote is used to treat bipolar disorder and certain types of seizures caused by epilepsy. Its also prescribed to prevent migraine headaches. Without insurance, Depakote costs $769 for 90, 500 mg delayed-release tablets.
A new U.S. government paper documenting an increase in maternal mortality from 2018 to 2022 does not hedge in its conclusion, calling the issue “an urgent public health priority.” That it was published amid massive job and funding cuts at federal health agencies charged with reducing these deaths has not escaped notice. A week ago, much of the department tasked with monitoring and improving maternal and child health at the Centers for Disease Control and Prevention was placed on le
A new Digital Architecture framework is anticipated to help transform the process of manufacturing pharmaceuticals, by helping companies to progress towards autonomous manufacturing.The digitalisation-focused initiative is a collaborationbetween the Centre for Process Innovation (CPI) and industry partners including AstraZeneca and GSK. This framework delivers a clear strategy for companies to incorporate digital technologies, enable real-time release for drug manufacturing and address key chall
A new Digital Architecture framework is anticipated to help transform the process of manufacturing pharmaceuticals, by helping companies to progress towards autonomous manufacturing.The digitalisation-focused initiative is a collaborationbetween the Centre for Process Innovation (CPI) and industry partners including AstraZeneca and GSK. This framework delivers a clear strategy for companies to incorporate digital technologies, enable real-time release for drug manufacturing and address key chall
Amid the hard-to-follow cutbacks at the U.S. Food and Drug Administration, a little-known but important office was eliminated — and the implications will be felt not only by drugmakers, but consumers. The Division of Policy Development in the Office of Generic Drug Policy, which was created more than a decade ago, was responsible for a host of activities that were central to ensuring generic drugs were approved properly for the American market.
The cancer biotech company Infinitopes has gained approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to evaluate its ITOP1 vaccine targeting oesophageal cancer. This marks the first ever trial to administer a cancer vaccine in a neoadjuvant setting while the primary tumour remains. With Clinical Trial Application (CTA) approval, the upcoming phase […] The post Infinitopes launches first-in-human trial of vaccine targeting oesophageal cancer appeared first on Phar
Two decades ago, when I first began practicing emergency medicine, patient documentation was a manual process. I would write on carbon-copy forms that were later stored in the belly of the hospital, in archives, as patient files. To get a lab test, an X-ray, or a medication for a patient, I had to jot down instructions on a piece of paper, track down the right nurse, and verbally convey what orders I had put in.
Benzodiazepines (BZDs) are FDA-approved for various conditions, such as anxiety, mood disorders, insomnia, and seizures. Although they treat a wide range of conditions, there are many safety concerns including increased risk of falls, cognitive impairment, delirium, and death, especially in concurrent use with central nervous system (CNS) depressants.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
GILA RIVER INDIAN COMMUNITY, Ariz. — Robert F. Kennedy Jr., speaking Tuesday morning at a conference on Native American tribal self-governance, was working hard to win his audience’s affection. But amid a measles outbreak linked to the deaths of two children and widespread turmoil inside the agency he oversees, Kennedy’s public appearances on a “MAHA Tour” of the Southwest this week were just as notable for the topics he avoided as those he discussed.
Good morning. Yesterday, there was a turkey (or, as one reporter guessed, a turkey vulture?) on the ledge outside STAT’s office windows all day. We’re on the third floor! Scroll all the way down for a picture of our new friend, and send in suggestions for a name. A harbinger of more growth in measles cases Cases in the West Texas measles outbreak are now appearing in urban areas, a formula for greater growth, Katherine Wells, director of public health for the city of Lubbock, told
In an update to the Journal of Pain Researchs formative meta-analysis on pain management in the US, researchers focused on the racial and ethnic disparities in access to pain treatment.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Hey there. Today, we talk about the NIH’s database ban on researchers in countries including China and Russia, discuss the legality of the HHS firings, and more. Pining for the days when biotech delivered good news The XBI fell more than 4% yesterday. The closely tracked index of biotech stocks is now down 13% since the announcement of President Trump’s tariff policy.
Expert on pain medicine, Mark Garofoli, PharmD, BCGP, CPE, joined Drug Topics to discuss trends in the safety and efficacy of OTC pain medications and what products patients often seek at the pharmacy.
“This year is going to be the year AI agents are going to get deployed,” NVIDIA CEO Jensen Huang declared at this year’s Consumer Electronics Show. But what are AI agents, and how do they apply to health care? Several health tech companies have jumped in on agents. One of the early entrants, Hippocratic AI, has a lineup of AI “nurses” that health systems can deploy for specific workflows, such as discussing cervical cancer screening or checking in on a chronic
Stephanie Downing, MBA, discusses expanding pharmacy services, clinical workflow efficiency, and revenue growth, highlighting the shift from traditional pharmacy roles to providing expanded clinical services.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
“There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the U.S. to invest at least $15 billion into the sector over the next five years.
Micah Cost, PharmD, MS, CAE, CEO of the Pharmacy Quality Alliance, hosted the keynote session at the Total Pharmacy Solutions Summit Spring 2025 event.
Huntington disease (HD) has no curative treatments, therefore, there is a great need for therapies that can reduce or slow the progression of symptoms.
Data from the HERCULES phase 3 trial were presented at the 2025 Annual Meeting for the American Academy of Neurology for non-relapsing secondary progressive multiple sclerosis.
Monetary incentives to receive a COVID-19 vaccine at a public vaccination event may have invertedly turned away others from receiving a booster, emphasizing the importance of recognizing spillover in trials addressing vaccine hesitancy.
Google Cloud continues to quickly build out its generative AI capabilities and is advancing technology for the adoption and use of AI agents to automate tasks and collaborate across organizations.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content